oral tirzepatide drops vs. Injections: A Game-Changing Weight Loss Alternative Tirzepatide Oral Drops

However, the STEP trial data suggests semaglutide is still effective in people on antidepressants

547 The Phase III trial of olpasiran aims to compare its effects with the placebo on the risk of coronary heart disease death, myocardial infarction, and urgent coronary revascularization in ASCVD patients with elevated Lp(a), with results expected by 2026 (NCT05581303)

IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1

AdH has received investigator-initiated clinical research funding from the AAN, has received consultant fees from Integra and Novo Nordisk, has received royalty fees from UpToDate, and has equity in Titin KM and Certus